XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Instruments and Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Cash Equivalents Measured at Fair Value on a Recurring Basis

The following table shows our cash and cash equivalents that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy, as well as their classification on our unaudited condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023:

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

Amortized Cost

 

 

Fair Value (1)

 

 

Cash and Cash Equivalents

 

 

Amortized Cost

 

 

Fair Value (1)

 

 

Cash and Cash Equivalents

 

 

 

(in millions)

 

Cash

 

$

820

 

 

$

820

 

 

$

820

 

 

$

685

 

 

$

685

 

 

$

685

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

351

 

 

 

351

 

 

 

351

 

 

 

382

 

 

 

382

 

 

 

382

 

Total

 

$

1,171

 

 

$

1,171

 

 

$

1,171

 

 

$

1,067

 

 

$

1,067

 

 

$

1,067

 

We did not have any unrealized gains and losses related to our cash equivalents.
Notional Principal Amounts of Outstanding Derivative Instruments

The following table shows the notional principal amounts of our outstanding derivative instruments for the periods presented:

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

(in millions)

 

 Foreign currency exchange-forward contracts (1)(2)

 

$

37

 

 

$

9

 

(1)
Derivative contracts address foreign currency exchange fluctuations for the Euro versus the U.S. dollar. These outstanding derivatives are not designated as hedging instruments and have an original maturity period of 90 days or less.
(2)
The fair value of our outstanding derivatives as of March 31, 2024 and December 31, 2023, respectively, was not material. The notional amount of a forward contract is the contracted amount of foreign currency to be exchanged and is not recorded on the unaudited condensed consolidated balance sheets.
Schedule of Accounts Receivable, Allowance for Expected Credit Loss

The following table provides information about the opening and closing balances of accounts receivable, including contract assets, net of allowance for expected credit losses, from contracts with customers as of the dates presented:

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

(in millions)

 

Accounts receivable

 

 

223

 

 

 

177

 

Contract assets

 

 

25

 

 

 

15

 

  Total

 

$

248

 

 

$

192

 

Schedule of Aggregate Principal and Fair Value Amount of Outstanding 2025 Senior Notes and 2026 Senior Notes

The following table shows the aggregate principal and fair value amount of the 2025 Senior Notes and 2026 Senior Notes as of the dates presented, which are classified as long-term debt on our unaudited condensed consolidated balance sheets and are considered Level 2 fair value measurements. Refer to “Note 6: Debt” for additional information on the 2025 Senior Notes and 2026 Senior Notes.

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

(in millions)

 

 2025 Senior Notes

 

 

 

 

 

 

   Aggregate principal amount

 

$

500

 

 

$

500

 

   Carrying value amount (1)

 

 

497

 

 

 

497

 

   Fair value amount (2)

 

 

502

 

 

 

502

 

 

 

 

 

 

 

 

 2026 Senior Notes

 

 

 

 

 

 

   Aggregate principal amount

 

$

345

 

 

$

345

 

   Carrying value amount (3)

 

 

343

 

 

 

342

 

   Fair value amount (2)

 

 

323

 

 

 

304

 

(1)
Net of $3 million of unamortized debt issuance costs as of both March 31, 2024 and December 31, 2023.
(2)
We estimate the fair value of the 2025 Senior Notes and 2026 Senior Notes based on recently reported market transactions and/or prices for identical or similar financial instruments obtained from a third-party pricing source.
(3)
Net of $2 million and $3 million of unamortized debt issuance costs as of March 31, 2024 and December 31, 2023, respectively.